Impact BioMedical Inc.
IBO
$0.4324
$0.00741.74%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 53.09% | 10.53% | 1.91% | 24.89% | 24.47% |
| Depreciation & Amortization | -0.09% | 0.18% | 0.18% | 0.45% | 0.63% |
| Other Operating Expenses | 50.00% | 870.59% | 1,045.45% | 1,585.71% | -- |
| Total Operating Expenses | -15.62% | -6.58% | -3.16% | 13.39% | 17.43% |
| Operating Income | 15.62% | 6.58% | 3.16% | -15.03% | -19.17% |
| Income Before Tax | -461.27% | 113.08% | 47.27% | 42.10% | 43.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -462.02% | 116.86% | 42.95% | 37.14% | 38.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -75.40% | -72.61% | -74.47% | -70.91% | 17.21% |
| Net Income | -494.61% | 118.48% | 41.73% | 35.53% | 40.05% |
| EBIT | 15.62% | 6.58% | 3.16% | -15.03% | -19.17% |
| EBITDA | 15.66% | -0.52% | -13.79% | -51.27% | -77.36% |
| EPS Basic | -2,506.48% | 259.60% | -135.49% | -73.32% | 15.35% |
| Normalized Basic EPS | 147.13% | 360.06% | -366.25% | -264.11% | -71.77% |
| EPS Diluted | -2,451.64% | -81.58% | -137.24% | -89.48% | 1.02% |
| Normalized Diluted EPS | -237.03% | -197.41% | -366.25% | -264.11% | -71.77% |
| Average Basic Shares Outstanding | -82.15% | -78.37% | -57.45% | -35.99% | -14.54% |
| Average Diluted Shares Outstanding | -57.05% | -56.91% | -57.45% | -35.99% | -14.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |